Australia's health watchdog accused of 'too close' relationship with industry

By Joanne McCarthy
November 6 2017 - 5:30am
Calls for major overhaul of the Therapeutic Goods Administration because of mesh failures

AUSTRALIA’S drug and medical device watchdog, the Therapeutic Goods Administration, needs a complete overhaul to distance it from the health industry and allow consumers to sue it for negligence, say academics and consumer advocates after the regulator quietly announced moves to classify all pelvic mesh devices high risk after years of controversy.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Newcastle news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.